<DOC>
	<DOCNO>NCT00989209</DOCNO>
	<brief_summary>Objective : Quantify benefit myofunctional therapy associate botulinum toxin injection patient long stand facial unilateral palsy .</brief_summary>
	<brief_title>Myofunctional Therapy Facial Palsy</brief_title>
	<detailed_description>Twenty-five patient long stand facial palsy study ; previously treat facial reanimation . Patients randomly divide two group ; Group A myofunctional therapy session speech therapist botulinum toxin injection , participant Group B myofunctional therapy .</detailed_description>
	<mesh_term>Facies</mesh_term>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Facial Paralysis</mesh_term>
	<mesh_term>Bell Palsy</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>facial paralysis 2 year elapse since onset symptom surgically treated reanimation least 12 month static and/or dynamic facial asymmetry cause aesthetic concern spastic paralysis serious systemic neuromuscular disease cognition impairment pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>62 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>facial paralysis</keyword>
	<keyword>asymmetry</keyword>
	<keyword>myofunctional therapy</keyword>
	<keyword>botulinum toxin</keyword>
	<keyword>facial evaluation</keyword>
</DOC>